Soligenix (NASDAQ: SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy – Financial News
Austin, Texas, United States, April 2nd, 2026, FinanceWire Soligenix (NASDAQ: SNGX) announced the publication of positive results from its comparability study evaluating HyBryte(TM) versus Valchlor(R) […]










